FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Free Newsletter

About | View Sample | Privacy
Related Topics >> FDA | analysts | Schwarz Pharma | FDA approval

ALSO NOTED: Ivax wins FDA approval; Reformulated Clarinex gains regulatory OK; Schwarz buys remaining rotigotine rights; and mu

Tools

> The FDA has given Miami-based Ivax final approval for hydrochlorothiazide capsules 12.5 mg. Release

> The FDA has approved a reformulated version of Clarinex for allergies. Release

> Analysts applauded news that Schwarz Pharma had bought out the remaining rights to rotigotine. Story

> Dusa Pharmaceuticals reported lower-than-expected second quarter sales. Release

And Finally... In a new paper in Science, researchers and ethicists discuss the potential ethical dilemmas surrounding the use of monkeys in testing brain cell therapy, such as creating a monkey with a human-like mind. Article


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:

More stories about FDA   analysts   Schwarz Pharma   FDA approval